Godwin, C. D., Bates, O. M., Garling, E. E., Beddoe, M. E., Laszlo, G. S., & Walter, R. B. (2020). The Bruton’s Tyrosine Kinase (BTK) Inhibitor Ibrutinib Abrogates Bispecific Antibody-Mediated T-cell Cytotoxicity. Br J Haematol.
शिकागो स्टाइल उद्धरणGodwin, Colin D., Olivia M. Bates, Eliotte E. Garling, Mary E. Beddoe, George S. Laszlo, और Roland B. Walter. "The Bruton’s Tyrosine Kinase (BTK) Inhibitor Ibrutinib Abrogates Bispecific Antibody-Mediated T-cell Cytotoxicity." Br J Haematol 2020.
एमएलए उद्धरणGodwin, Colin D., et al. "The Bruton’s Tyrosine Kinase (BTK) Inhibitor Ibrutinib Abrogates Bispecific Antibody-Mediated T-cell Cytotoxicity." Br J Haematol 2020.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.